Home Recalls D-0426-2021
Class II · Moderate risk Terminated Initiated Mar 15, 2021 (5 years ago)
Enoxaparin Dofium Injrvyion, Upd 150mg/1ml 10x1ml Single Dose Syringes; Ndc/Upc…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
What was recalled
ENOXAPARIN DOFIUM INJRVYION, UPD 150MG/1ML 10X1ML SINGLE DOSE SYRINGES; NDC/UPC 60505-0798-4; RX; SYRINGES
Recalling firm Cardinal Health Inc.
Origin OH, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-0426-2021
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Class II · Moderate risk Ongoing Aug 5, 2025
Reason Correct Labeled Product Mispack: Bags labeled for Enoxaparin Sodium Injection, 80 mg/0.8 mL, contained Enoxaparin Sodium Injection, 30 mg/0.3 mL
Class II · Moderate risk Terminated Jan 26, 2022
Reason CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class I · High risk Completed Nov 17, 2021
Reason Temperature Abuse; temperature excursion during shipping
Class I · High risk Ongoing Feb 2, 2021
Reason Labeling; Label Mixup; syringe barrels may contain markings for 100 mg/mL (corresponding to 100 mg/mL strength) instead of 150 mg/mL (corresponding…
Class I · High risk Ongoing Feb 2, 2021
Reason Labeling; Label Mixup; syringe barrels may containing markings for 150 mg/mL (corresponding to 120 mg/0.8mL strength) instead of 100 mg/mL markings…